Despite the presence of large number and diverse populations of commensal microbes, gut mucosa has evolved to maintain “microbial-tolerance”, which is critically regulated by well-controlled Toll-like receptor (TLR) signaling. Deregulated TLR signaling has been linked to the pathogenesis of inflammatory bowel disease and colon cancer; however, the underlying mechanisms need to be further defined. In this study, we uncovered that lack of SIGIRR, a negative regulator for TLR and IL-1R signaling, led to increased genetic instability and LOH of Apc, resulting in spontaneous colonic polyposis in Apcmin/+/Sigirr-/- mice. Importantly, elevated colonic tumorigenesis in Apcmin/+/Sigirr-/- mice is dependent on the presence of commensal microbes in gut, implicating a critical role for TLR signaling in tumorigenesis. Furthermore, we demonstrated that SIGIRR-modulated TLR-mediated tumor initiation is mainly through the activation of the Akt-mTOR axis, which promotes cell cycle progression through its impact on posttranscriptional control of the key cell cycle regulators (Cyclins, c-Myc and cdk2). Moreover, abrogation of mTOR pathway by rapamycin prevented microadenoma and polyps formation in Apcmin/+/Sigirr-/- mice, providing new insights into treating human cancers. In addition, augmented production of proinflammatory cytokines, such as IL-6 and IL-23, further promoted tumor growth in Apcmin/+/Sigirr-/- mice. Epithelium specific re-expression of SIGIRR in Apcmin/+/Sigirr-/- mice ameliorated intestinal tumorigenesis. In summary, this study indicates that SIGIRR is a critical tumor suppressor that controls tumorigenesis by inhibiting TLR-induced mTOR and NFkB pathways in colonic epithelium.
. 2011 Jan 10;5(Suppl 1):P87.
Toll-Like Receptors are critical in controlling colonic inflammation and cancer
Hui Xiao
1,2,✉, Weiguo Yin
2, Mohammed A Khan
3, Muhammet F Gulen
2, Bruce A Vallance
3, Xiaoxia Li
2
Hui Xiao
1Unit of Immune Signaling and Regulation, Institut Pasteur of Shanghai, Shanghai 200025, PR China
2Department of Immunology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
Find articles by Hui Xiao
Weiguo Yin
2Department of Immunology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
Find articles by Weiguo Yin
Mohammed A Khan
3Division of Gastroenterology, University of British Columbia and BC Children’s Hospital, Vancouver, BC V6T 1Z4, Canada
Find articles by Mohammed A Khan
Muhammet F Gulen
2Department of Immunology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
Find articles by Muhammet F Gulen
Bruce A Vallance
3Division of Gastroenterology, University of British Columbia and BC Children’s Hospital, Vancouver, BC V6T 1Z4, Canada
Find articles by Bruce A Vallance
Xiaoxia Li
2Department of Immunology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
Find articles by Xiaoxia Li
1Unit of Immune Signaling and Regulation, Institut Pasteur of Shanghai, Shanghai 200025, PR China
2Department of Immunology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
3Division of Gastroenterology, University of British Columbia and BC Children’s Hospital, Vancouver, BC V6T 1Z4, Canada
✉
Corresponding author.
Supplement
Institut Pasteur International Network Annual Scientific Meeting
Roberto Bruzzone
Conference
22–23 November 2010
Institut Pasteur International Network Annual Scientific Meeting
Hong Kong
Collection date 2011.
Copyright ©2011 Xiao et al; licensee BioMed Central Ltd.
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
PMCID: PMC3019517
